Rezension:
Sorry, I ran out of credit acknowledgement for thesis A likely sticking point in negotiations will be whether LTSLohmann can succeed in preventing generic drugmakers fromlaunching cheap copies of its Exelon patch for mild to moderatedementia. Novartis has sued Actavis for trying to bringits version to market.
